Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression

Kunwei Peng(Sun Yat-sen University Cancer Center), Liangping Xia(Sun Yat-sen University)
Cellular Oncology
February 5, 2024
Cited by 6


Related Papers